Hansen Medical Announces Key Developments in Global Expansion Strategy

MOUNTAIN VIEW, CA--(Marketwired - Dec 19, 2014) - Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced key recent developments in the company's global expansion strategy. Hansen and AB Medica s.p.a today announced an exclusive distribution agreement for Magellan™ and Sensei® Robotic Systems in Italy. In addition, the company's exclusive distribution partner in Kingdom of Saudi Arabia and United Arab Emirates, AFYA Medical Group, completed the first end user hospital installation of a Magellan system in the Middle East, at King Fahd Hospital in Jeddah, Saudi Arabia, in October.

"We are pleased to enter into this comprehensive distribution partnership with AB Medica, Italy's largest medical technology distributor; and for the progress we are making with our other international partners such as AFYA," said Cary Vance, Hansen Medical President and CEO. "Coupled with our announcement in July of an exclusive distribution agreement with Adachi Co., Ltd. in Japan, we feel good about the foundation we are laying for development of a strong global market for our intravascular robotics technologies."

Hansen Medical's intravascular robotic technologies are designed to deliver accurate robotic catheter control and stability during a wide variety of endovascular and electrophysiology (EP) procedures. Both the Magellan and Sensei Robotic Systems provide for accurate navigation capabilities while allowing the physician to be seated comfortably away from the radiation in a centralized, remote workstation. 

About the Magellan™ Robotic System
Hansen Medical's Magellan Robotic System is intended to be used to facilitate navigation in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The Magellan Robotic System is designed to deliver predictability, control and catheter stability to endovascular procedures. Since its commercial introduction in the U.S. and Europe, the Magellan Robotic System has demonstrated its clinical versatility in many cases in a broad variety of peripheral vascular procedure types in centers across the U.S. and Europe. The Magellan Robotic System offers several important features including: